Published on 10 May 2024 on GuruFocus.com via Yahoo Finance
Applied Therapeutics Inc (APLT) Reports Q1 2024 Earnings: A Deep Dive into Financials and ...
Revenue: Reported at $190K for Q1 2024, significantly below estimates of $3.33M.Net Loss: Increased to $83.94M in Q1 2024, far exceeding the estimated net loss of $16.72M.Earnings Per Share (EPS): Recorded a loss of $0.67 per share, deeper than the estimated loss of $0.16 per share.Cash and Cash Equivalents: Increased to $146.48M as of March 31, 2024, up from $49.90M as of December 31, 2023.Research and Development Expenses: Amounted to $12.22M, showing a decrease from the previous year's $15.94M.General and Administrative Expenses: Rose to $9.07M from $5.58M in the corresponding period last year.Total Assets: Grew to $151.23M, up from $54.83M at the end of the previous year.
Warning! GuruFocus has detected 4 Warning Signs with APLT.